- Home
- EQ vs LVO Comparison
EQ vs LVO Comparison
Compare EQ & LVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQ
- LVO
- Stock Information
- Founded
- EQ 2017
- LVO 2009
- Country
- EQ United States
- LVO United States
- Employees
- EQ N/A
- LVO N/A
- Industry
- EQ Biotechnology: Pharmaceutical Preparations
- LVO Restaurants
- Sector
- EQ Health Care
- LVO Consumer Discretionary
- Exchange
- EQ Nasdaq
- LVO Nasdaq
- Market Cap
- EQ 67.9M
- LVO 68.1M
- IPO Year
- EQ 2018
- LVO N/A
- Fundamental
- Price
- EQ $1.50
- LVO $0.52
- Analyst Decision
- EQ Hold
- LVO Strong Buy
- Analyst Count
- EQ 2
- LVO 2
- Target Price
- EQ $1.00
- LVO $1.40
- AVG Volume (30 Days)
- EQ 2.5M
- LVO 895.4K
- Earning Date
- EQ 11-12-2025
- LVO 11-06-2025
- Dividend Yield
- EQ N/A
- LVO N/A
- EPS Growth
- EQ N/A
- LVO N/A
- EPS
- EQ N/A
- LVO N/A
- Revenue
- EQ $16,553,000.00
- LVO $100,534,000.00
- Revenue This Year
- EQ N/A
- LVO N/A
- Revenue Next Year
- EQ N/A
- LVO $24.07
- P/E Ratio
- EQ N/A
- LVO N/A
- Revenue Growth
- EQ N/A
- LVO N/A
- 52 Week Low
- EQ $0.27
- LVO $0.43
- 52 Week High
- EQ $2.35
- LVO $1.60
- Technical
- Relative Strength Index (RSI)
- EQ 48.79
- LVO 45.93
- Support Level
- EQ $1.78
- LVO $0.52
- Resistance Level
- EQ $2.02
- LVO $0.55
- Average True Range (ATR)
- EQ 0.26
- LVO 0.05
- MACD
- EQ -0.09
- LVO 0.01
- Stochastic Oscillator
- EQ 1.73
- LVO 58.19
About EQ Equillium Inc.
Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its product candidates either independently or through partnerships, or otherwise monetize its pipeline through strategic transactions. Itolizumab (EQ001), a clinical-stage product candidate, is an anti-CD6 immune-modifying monoclonal antibody, or mAb, that selectively targets the CD6-ALCAM signaling pathway to downregulate pathogenic T effector cells while preserving T regulatory cells critical for maintaining a balanced immune response. The company's other clinical-stage and pre-clinical-stage candidates include EQ101 and EQ302.
About LVO LiveOne Inc.
LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.